Results 71 to 80 of about 3,497,436 (306)

Blood‐based proteomic profiling reveals context‐dependent changes in BCL2‐associated signaling during taxane therapy in breast cancer patients

open access: yesFEBS Open Bio, EarlyView.
Chemotherapy side effects significantly impact cancer survivors' quality of life. Using protein levels in blood samples from breast cancer patients before and after 12 weeks of taxane treatment, we detected treatment‐dependent changes in calcium signaling and aging pathways associated with cancer recurrence.
Saira Munshani   +6 more
wiley   +1 more source

Ohio cancer incidence and mortality report, an analysis of incidence and mortality data

open access: yes, 2009
Annual; 1997/2001-; "The Ohio Department of Health [and] Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University."; Vol.

core  

PINK1 suppresses malignant phenotypes in esophageal squamous cell carcinoma

open access: yesWorld Journal of Surgical Oncology
Objective Esophageal squamous cell carcinoma (ESCC) is a common tumor characterized by a poor prognosis. PINK1 is strongly associated with tumorigenesis. However, the role of PINK1 in the progression of ESCC has not been elucidated.
Xiangyun Lu   +6 more
doaj   +1 more source

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

open access: yesFEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin   +12 more
wiley   +1 more source

U.S. cancer statistics : Highlights from 2019 incidence [PDF]

open access: yes
In 2019, a total of 1,752,735 new invasive cancer cases were reported in the United States: 863,830 among females and 888,905 among males. For all cancers combined, the incidence rate was 439 per 100,000 standard population overall.

core   +2 more sources

Correction to: AT1R gene rs389566 polymorphism contributes to MACCEs in hypertension patients

open access: yesBMC Cardiovascular Disorders, 2023
Jun-Yi Luo   +8 more
doaj   +1 more source

Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma

open access: yesCancer Communications, 2018
Background Esophageal squamous cell carcinoma (ESCC) is the predominant subtype of esophageal carcinoma in China. This study was to develop a staging model to predict outcomes of patients with ESCC.
Jin-Cheng Guo   +11 more
doaj   +1 more source

Molecular characterization of covRS mutations in M1UK Streptococcus pyogenes

open access: yesFEBS Open Bio, EarlyView.
Group A Streptococcus (GAS) acquires covRS mutations driving a hypervirulent bacterial state, frequently associated with invasive disease‐like necrotizing fasciitis. We demonstrate that the newly emerged M1UK GAS lineage can also acquire these mutations.
Jarrad Pritchard   +12 more
wiley   +1 more source

Cancer incidence in Italian contaminated sites.

open access: yes, 2014
Introduction. The incidence of cancer among residents in sites contaminated by pollut¬ants with a possible health impact is not adequately studied. In Italy, SENTIERI Project (Epidemiological study of residents in National Priority Contaminated Sites ...
Fusco M   +14 more
core   +1 more source

Exploring the Anti-Cervical Cancer Effect and Hepatotoxicity Risk of Gossypol Based on Untargeted Metabolomics and Network Toxicology

open access: yesPharmaceuticals
Objectives: This research sought to examine the impact of gossypol on cervical cancer tumors that have been transplanted subcutaneously in nude mice, as well as the associated risk of liver damage and its underlying mechanisms.
Jinyan Li   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy